HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pierre I Karakiewicz Selected Research

Frailty

1/2023A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy-A large, retrospective, single-center study.
1/2022The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy.
9/2021Partial nephrectomy in frail patients: Benefits of robot-assisted surgery.
12/2020Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy.
3/2020Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy.
3/2020Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pierre I Karakiewicz Research Topics

Disease

343Neoplasms (Cancer)
04/2024 - 04/2002
325Prostatic Neoplasms (Prostate Cancer)
04/2024 - 02/2002
191Carcinoma (Carcinomatosis)
04/2024 - 02/2006
120Urinary Bladder Neoplasms (Bladder Cancer)
03/2024 - 02/2005
116Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 06/2007
62Neoplasm Metastasis (Metastasis)
04/2024 - 06/2005
40Margins of Excision
11/2023 - 12/2005
40Lymphatic Metastasis
05/2023 - 10/2006
22Kidney Neoplasms (Kidney Cancer)
03/2024 - 10/2007
21Disease Progression
04/2024 - 09/2007
20Non-Muscle Invasive Bladder Neoplasms
07/2023 - 05/2010
17Carcinoma in Situ
01/2019 - 09/2006
17Transitional Cell Carcinoma
04/2014 - 05/2005
13Adenocarcinoma
06/2023 - 05/2007
11Extranodal Extension
01/2017 - 12/2005
10Intraoperative Complications
03/2024 - 04/2012
9Obesity
01/2021 - 08/2007
8Necrosis
11/2023 - 04/2010
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 02/2012
7Hypertension (High Blood Pressure)
11/2023 - 09/2009
6Diabetes Mellitus
11/2023 - 08/2009
6Frailty
01/2023 - 03/2020
6Inflammation (Inflammations)
06/2022 - 01/2020
6Erectile Dysfunction
01/2021 - 01/2006
5Carcinogenesis
04/2022 - 01/2008
5Urinary Incontinence
11/2021 - 11/2012
4Hemorrhage
03/2024 - 08/2019
4Clear-cell metastatic renal cell carcinoma
12/2023 - 01/2016
4Renal Insufficiency (Renal Failure)
01/2019 - 06/2009
3Thrombosis (Thrombus)
04/2024 - 04/2008
3Urethral Neoplasms (Urethral Cancer)
04/2024 - 01/2020
3Infections
03/2024 - 04/2004
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2023 - 09/2006

Drug/Important Bio-Agent (IBA)

61Prostate-Specific Antigen (Semenogelase)IBA
01/2024 - 03/2002
41Biomarkers (Surrogate Marker)IBA
11/2023 - 02/2007
27AndrogensIBA
04/2024 - 06/2005
12Hormones (Hormone)IBA
04/2024 - 04/2006
12AntigensIBA
12/2022 - 03/2008
10Indicators and Reagents (Reagents)IBA
01/2022 - 04/2010
9Immune Checkpoint InhibitorsIBA
04/2024 - 01/2021
9AlbuminsIBA
01/2023 - 08/2020
9GlobulinsIBA
03/2022 - 08/2020
9Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2021 - 03/2008
8Proteins (Proteins, Gene)FDA Link
01/2023 - 05/2007
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2008
7Plasminogen Activators (Plasminogen Activator)IBA
01/2021 - 03/2008
7Sunitinib (Sutent)FDA Link
01/2021 - 06/2007
7nuclear matrix protein 22IBA
03/2012 - 05/2005
6Docetaxel (Taxotere)FDA Link
04/2024 - 01/2018
6Androgen Receptors (Androgen Receptor)IBA
04/2024 - 11/2020
6isopropyl cyanoacrylateIBA
03/2024 - 08/2008
6Dihydrotachysterol (AT 10)IBA
06/2023 - 02/2009
6C-Reactive ProteinIBA
01/2023 - 09/2007
6EndoglinIBA
01/2022 - 03/2008
6Tyrosine Kinase InhibitorsIBA
01/2022 - 02/2012
5enzalutamideIBA
12/2023 - 01/2018
5Hemoglobins (Hemoglobin)IBA
11/2023 - 08/2019
5Cisplatin (Platino)FDA LinkGeneric
05/2023 - 06/2008
5Caveolin 1IBA
08/2022 - 05/2007
5Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2022 - 08/2014
5Serum AlbuminIBA
10/2021 - 01/2021
5SurvivinIBA
11/2015 - 02/2007
5temsirolimusFDA Link
04/2014 - 05/2008
4Cholinesterases (Cholinesterase)IBA
07/2023 - 12/2018
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2022 - 07/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2008
4Urokinase Plasminogen Activator ReceptorsIBA
10/2020 - 06/2009
4Metformin (Glucophage)FDA LinkGeneric
10/2018 - 12/2013
4Cadherins (E-Cadherin)IBA
08/2017 - 11/2011
3darolutamideIBA
12/2023 - 11/2020
3apalutamideIBA
12/2023 - 11/2020
3Mitomycin (Mitomycin-C)FDA LinkGeneric
05/2023 - 05/2010
3GemcitabineFDA Link
05/2023 - 06/2008
3DNA (Deoxyribonucleic Acid)IBA
12/2022 - 09/2006

Therapy/Procedure

258Prostatectomy (Retropubic Prostatectomy)
03/2024 - 02/2002
157Therapeutics
04/2024 - 06/2005
156Cystectomy
08/2023 - 02/2005
109Nephrectomy
04/2024 - 04/2007
101Lymph Node Excision (Lymph Node Dissection)
04/2024 - 05/2006
81Radiotherapy
03/2024 - 08/2006
79Nephroureterectomy
04/2024 - 10/2008
52Drug Therapy (Chemotherapy)
03/2024 - 04/2006
31Adjuvant Chemotherapy
04/2017 - 10/2006
24Length of Stay
03/2024 - 08/2011
19Neoadjuvant Therapy
08/2023 - 10/2006
15Blood Transfusion (Blood Transfusions)
03/2024 - 04/2007
14Immunotherapy
04/2024 - 12/2012
11Transurethral Resection of Bladder
03/2024 - 03/2013
10Adjuvant Radiotherapy
10/2019 - 10/2006
9Castration
12/2023 - 01/2019
7Brachytherapy
01/2022 - 12/2015
5Aftercare (After-Treatment)
12/2023 - 08/2016
5Transurethral Resection of Prostate (TURP)
01/2023 - 08/2009
4Catheters
11/2021 - 06/2011
4Orchiectomy (Orchidectomy)
12/2019 - 12/2014
3Palliative Care (Palliative Therapy)
04/2024 - 11/2019
3Critical Care (Surgical Intensive Care)
03/2024 - 11/2019
3Combined Modality Therapy
03/2024 - 03/2014
3Intravesical Administration
05/2023 - 05/2014
3Cryosurgery
01/2023 - 12/2013